|
ZNF543 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01310000388821E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.6019999982706E-08 |
| Normal-vs-Stage2 |
1.8772999999972E-05 |
| Normal-vs-Stage3 |
7.9315000123259E-09 |
| Normal-vs-Stage4 |
6.11540040829084E-10 |
| Stage1-vs-Stage2 |
6.639800E-01 |
| Stage1-vs-Stage3 |
2.691800E-01 |
| Stage1-vs-Stage4 |
2.826400E-02 |
| Stage2-vs-Stage3 |
2.729600E-01 |
| Stage2-vs-Stage4 |
6.826200E-02 |
| Stage3-vs-Stage4 |
3.394200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.94500001952036E-09 |
| Normal-vs-AfricanAmerican |
5.339100E-03 |
| Normal-vs-Asian |
1.45719999999905E-06 |
| Caucasian-vs-AfricanAmerican |
8.295600E-02 |
| Caucasian-vs-Asian |
4.662600E-01 |
| AfricanAmerican-vs-Asian |
2.926400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.32249999629641E-08 |
| Normal-vs-Female |
9.49800005312085E-09 |
| Male-vs-Female |
7.778600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83670000214664E-08 |
| Normal-vs-Age(41-60Yrs) |
1.39539999555183E-08 |
| Normal-vs-Age(61-80Yrs) |
2.34229999840352E-08 |
| Normal-vs-Age(81-100Yrs) |
3.604100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.996400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.336600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.129200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.790600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.547600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.306400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.806400E-02 |
| Classical-VS-Follicular |
3.818000E-02 |
| Classical-VS-Other |
8.953200E-01 |
| Classical-VS-Normal |
2.92059999962291E-07 |
| Tall-VS-Follicular |
5.257400E-01 |
| Tall-VS-Other |
3.587400E-01 |
| Tall-VS-Normal |
1.05120000482017E-08 |
| Follicular-VS-Other |
6.046800E-01 |
| Follicular-VS-Normal |
1.0407000039514E-08 |
| Other-VS-Normal |
3.011800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66210000207556E-08 |
| Normal-vs-N1 |
2.93320001620856E-09 |
| N0-vs-N1 |
2.277800E-01 |
|
|
